BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36193432)

  • 1. BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect
    Liu X; Liu H; Zeng L; Lv Y
    PeerJ; 2022; 10():e14052. PubMed ID: 36193432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.
    Yi YW; Kang HJ; Kim HJ; Hwang JS; Wang A; Bae I
    Mol Carcinog; 2013 Sep; 52(9):667-75. PubMed ID: 22488590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.
    Qian Y; Bi L; Yang Y; Wang D
    Anticancer Drugs; 2018 Aug; 29(7):616-627. PubMed ID: 29782350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
    Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
    Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer.
    Okrah EA; Wang Q; Fu H; Chen Q; Gao J
    Anticancer Drugs; 2020 Nov; 31(10):1046-1056. PubMed ID: 32649369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
    Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
    Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bag-1 silencing enhanced chemotherapeutic drug-induced apoptosis in MCF-7 breast cancer cells affecting PI3K/Akt/mTOR and MAPK signaling pathways.
    Kilbas PO; Akcay IM; Doganay GD; Arisan ED
    Mol Biol Rep; 2019 Feb; 46(1):847-860. PubMed ID: 30661182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.
    Hinton CV; Fitzgerald LD; Thompson ME
    Exp Cell Res; 2007 May; 313(9):1735-44. PubMed ID: 17428466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose restriction reverses the Warburg effect and modulates PKM2 and mTOR expression in breast cancer cell lines.
    Tahtouh R; Wardi L; Sarkis R; Hachem R; Raad I; El Zein N; Hilal G
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):26-33. PubMed ID: 31880514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted pyruvate kinase M2 facilitates cell migration via PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells.
    Yang P; Li Z; Wang Y; Zhang L; Wu H; Li Z
    Biochem Biophys Res Commun; 2015 Apr; 459(2):327-332. PubMed ID: 25732087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.
    Gonzalez ME; DuPrie ML; Krueger H; Merajver SD; Ventura AC; Toy KA; Kleer CG
    Cancer Res; 2011 Mar; 71(6):2360-70. PubMed ID: 21406404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway.
    Li J; Qu P; Zhou XZ; Ji YX; Yuan S; Liu SP; Zhang QG
    Biomed Pharmacother; 2022 Jun; 150():113063. PubMed ID: 35658233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
    Zhu Y; Liu Y; Zhang C; Chu J; Wu Y; Li Y; Liu J; Li Q; Li S; Shi Q; Jin L; Zhao J; Yin D; Efroni S; Su F; Yao H; Song E; Liu Q
    Nat Commun; 2018 Apr; 9(1):1595. PubMed ID: 29686231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.
    Sun Y; Chen Y; Xu M; Liu C; Shang H; Wang C
    Biomed Res Int; 2020; 2020():9243681. PubMed ID: 32685545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
    Li G; Xu D; Sun J; Zhao S; Zheng D
    Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.